Your session is about to expire
← Back to Search
This trial is testing a combination of drugs to see if it's safe and effective in treating patients with metastatic breast cancer, specifically those with the BRCA mutation.
- Metastatic Breast Cancer
- Breast Cancer
- BRCA1 Mutation
- BRCA2 Mutation
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Side effects dataFrom 2013 Phase 2 trial • 75 Patients • NCT01051596
Awards & Highlights
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Share this study with friends